TG Therapeutics
TGTX
TGTX
197 hedge funds and large institutions have $1.11B invested in TG Therapeutics in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 63 increasing their positions, 57 reducing their positions, and 24 closing their positions.
Holders
197
Holders Change
+16
Holders Change %
+8.84%
% of All Funds
3.18%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
63
Reduced
57
Closed
24
Calls
$79.4M
Puts
$52.5M
Net Calls
+$26.9M
Net Calls Change
-$3.53M
Top Buyers
1 |
1
Millennium Management
New York
|
$73.3M |
2 |
WP
2
Woodline Partners
San Francisco,
California
|
$30.3M |
3 |
3
D.E. Shaw & Co
New York
|
$26.1M |
4 |
4
Alkeon Capital Management
New York
|
$36M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$183M |